HEIP
AGN

Hudson Edge Investment Partners’s Allergan plc AGN Stock Holding History

Hudson Edge Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,556
Closed -$319K – 159
2017
Q3 		$319K Buy
1,556
+26
+2% +$6.05K 0.05% 134
2017
Q2 		$372K Sell
1,530
-400
-21% -$94K 0.05% 131
2017
Q1 		$461K Hold
1,930
– – 0.06% 117
2016
Q4 		$405K Sell
1,930
-10
-0.5% -$2.07K 0.06% 125
2016
Q3 		$447K Buy
+1,940
New +$474K 0.07% 105
2015
Q3 		– Sell
-972
Closed -$295K – 142
2015
Q2 		$295K Buy
+972
New +$290K 0.01% 131

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Hudson Edge Investment Partners's AGN Position: Q4 2017 in Review

Hudson Edge Investment Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,556 shares — an estimated $319K sold.

Hudson Edge Investment Partners first reported a position in AGN in Q2 2015 and held it in 6 quarters. The position peaked at $461K in Q1 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Hudson Edge Investment Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 1,556 Allergan plc shares in Q4 2017, an estimated $319K.
  • Hudson Edge Investment Partners first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Hudson Edge Investment Partners's Allergan plc position peaked at $461K in Q1 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Hudson Edge Investment Partners's 13F filing for Q4 2017, filed 8 Feb 2018.